Abstract

The costs of anticancer drug developments and licensing are skyrocketing, approximate 1-1.8 billions USD in US. So the anticancer drug costs in hospitals are also very expensive. Cost-effective study cancer therapy is an indispensable part of cancer therapy, especially for ICC.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call